Market Trends of Germany Pharmaceutical Cold Chain Logistics Industry
Growing Popularity of Online Pharmacies to Aid Market Expansion
Due to expanding internet usage and the rise in chronic diseases in developing nations, online pharmacies have become more and more popular in recent years. Germany is the market in Europe that is expanding the fastest, thanks to the availability of high-speed internet and the growing knowledge of the advantages of online over-the-counter products. One of Europe's most well-liked innovations is the online pharmacy, which is used in both developed and developing nations. The COVID-19 epidemic has had positive effects on the online pharmacy market. Customers flocked in droves and showed a significant interest in ordering drugs online.
Customers poured in by the thousands and showed a significant interest in buying drugs online. The German government's healthcare reform initiatives are also helping the online pharmacy market. One of these, the electronic prescription procedure, aims to reduce time, effort, and travel costs for both patients and healthcare professionals in the German healthcare system in the future. Additionally, it aims to make pharmacological therapy for patients safer. Following a medical consultation or video consultation, patients will receive a prescription code along with intake and dosage instructions displayed in the gematik app.
Once the nationwide rollout process is complete, all healthcare providers in Germany will also be required to write prescriptions digitally. They can either present the prescription code and redeem it at the pharmacy of their choosing, or they can redeem it online and have it delivered. The German online pharmacy group with the quickest growth is called apo.com Group.
The apo.com Group brands rose by more over 30% in 2022, while the online pharmacy market only expanded by 1.4% throughout the present crisis and after Corona. As a result, the company's market share rose from 7% to over 11% in 2022. The need for drugs from cold chain logistics will rise as internet pharmacies gain popularity in Germany.
Biopharmaceuticals to Contribute in Market Expansion
The development of biological medicines has had a huge impact on the pharmaceutical industry's landscape. With more than half of the active biopharmaceutical ingredients manufactured in the south of Germany, Germany is the top producer of EU-approved active biopharmaceutical substances on the European pharmaceutical market.
Lake Constance and Ulm are the main locations for this. More than 100 biotech, pharmaceutical, and medical technology companies, as well as research organizations, are located in the small region. The nation has consistently ranked highly within Europe, but studies reveal that in terms of manufacturing capacity, it has stayed in fifth place globally. This is mostly because other countries with more investments in the production of biopharmaceuticals have more competitive tax structures. Due to their excellent therapeutic potential, biologics have dramatically grown their market share in Germany's pharmaceutical sector. Revenues from biopharmaceuticals climbed by 34.0% in the third quarter of 2022 to reach EUR 1,265.2 million(USD 1418.35 Million).
Germany supports an innovative environment for the production of drugs in general as well as for biopharmaceutical companies. Businesses like Vetter, Teva, Biberach Site, and Boehringer Ingelheim continue to produce new products that can aid in the nation's advancements and expansion in the pharmaceutical industry. EuroDev has consistently assisted North American producers in these challenging markets with research, sales, and brand recognition for advising services on how to enter the German pharmaceutical industry. EuroDev provides ongoing guidance on the rules in effect, market dynamics, competition, customers, and difficulties you can encounter while trying to enter the German pharmaceutical market.
